Back
BioXcel Therapeutics Quote, Financials, Valuation and Earnings
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
31
BTAI
BioXcel Therapeutics
Last Price:
0.41
Seasonality Move:
80.92%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...BioXcel Therapeutics Price Quote
$0.41
0.00 (0.02%)
(Updated: December 14, 2024 at 5:26 AM ET)
BioXcel Therapeutics Key Stats
Sell
31
BioXcel Therapeutics (BTAI)
is a Sell
Day range:
$0.40 - $0.42
52-week range:
$0.36 - $4.17
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.47
P/B ratio:
0%
Volume:
248.2K
Avg. volume:
713.9K
1-year change:
-87.12%
Market cap:
$19.9M
Revenue:
$1.4M
EPS:
$-2.16
How Much Does BioXcel Therapeutics Make?
-
How Much Are BioXcel Therapeutics's Sales Annually?
BTAI Revenues are $1.4M -
How Much Profit Does BioXcel Therapeutics's Make A Year?
BTAI net income is -$179.1M
Is BioXcel Therapeutics Growing As A Company?
-
What Is BioXcel Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.37% -
What Is BioXcel Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioXcel Therapeutics Stock Price Performance
-
Did BioXcel Therapeutics Stock Go Up Last Month?
BioXcel Therapeutics share price went down by -33.42% last month -
Did BTAI's Share Price Rise Over The Last Year?
BTAI share price fell by -87.12% over the past 1 year
What Is BioXcel Therapeutics 52-Week High & Low?
-
What Is BioXcel Therapeutics’s 52-Week High Share Price?
BioXcel Therapeutics has traded as high as $4.17 over the past 52 weeks -
What Is BioXcel Therapeutics’s 52-Week Low Share Price?
BioXcel Therapeutics has traded as low as $0.36 over the past 52 weeks
BioXcel Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BioXcel Therapeutics?
-
How Much Debt Does BioXcel Therapeutics Have?
Total long term debt quarterly is $104.4M -
How Much Cash Does BioXcel Therapeutics Have?
Cash and short term investments quarterly total is $40.4M -
What Is BioXcel Therapeutics’s Book Value Per Share?
Book value per share is -2.02
Is BioXcel Therapeutics Cash Flow Positive?
-
What Is BTAI Cash Flow From Operations?
Cash flow from operations (TTM) is -$84.1M -
What Is BioXcel Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $34.5M -
What Is BioXcel Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
BioXcel Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
BTAI return on invested capital is -197.92% -
What Is BioXcel Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -95.73% -
What Is BTAI Return On Equity?
ROE is a measure of profitability and is 0%
BioXcel Therapeutics Earnings Date & Stock Price
-
What Is BioXcel Therapeutics's Stock Price Today?
A single share of BTAI can be purchased today for 0.41 -
What Is BioXcel Therapeutics’s Stock Symbol?
BioXcel Therapeutics trades on the nasdaq under the ticker symbol: BTAI -
When Is BioXcel Therapeutics’s Next Earnings Date?
The next quarterly earnings date for BioXcel Therapeutics is scheduled on March 12, 2025 -
When Is BTAI's next ex-dividend date?
BioXcel Therapeutics's next ex-dividend date is December 15, 2024 -
How To Buy BioXcel Therapeutics Stock?
You can buy BioXcel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioXcel Therapeutics Competitors
-
Who Are BioXcel Therapeutics's Competitors?
Below is a list of companies who compete with BioXcel Therapeutics or are related in some way:
BioXcel Therapeutics Dividend Yield
-
What Is BTAI Dividend Yield?
BioXcel Therapeutics’s dividend yield currently is 0% -
What Is BioXcel Therapeutics’s Payout Ratio?
BioXcel Therapeutics’s payout ratio is 0% -
When Did BioXcel Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is BioXcel Therapeutics’s Dividend Per Share?
BioXcel Therapeutics pays a dividend of $0.00 per share
BioXcel Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 33.33% |
| Revenue: | -37.24% | -83.88% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 5.00 |
| Upside from Last Price: | 1113.3% |